(HCM) often develop an extensive atrial substrate resulting in persistent atrial fibrillation (AF)
1, 2 and complex atrial tachycardia requiring multiple ablation procedures and …

Background The effects of disease-causing MYBPC3 or MYH7 genetic variants on atrial
myopathy, atrial fibrillation (AF) clinical course, and catheter ablation efficacy remain …

Genes associated with hypertrophic cardiomyopathy (HC) are not uniformly expressed in the
atrial myocardium. Whether this may impact susceptibility to atrial fibrillation (AF) is …

Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease caused by
mutations in genes coding for cardiac sarcomeres. HCM is the most common inherited heart …

Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic myocardial disorder
characterized by primary left ventricular hypertrophy. HCM is the most common inherited …

Background Hypertrophic cardiomyopathy (HCM) is the most common inherited
cardiovascular disease that affects approximately one in 500 people. HCM is a recognized …

Current guidelines have emphasized the central role of catheter ablation in the management
of patients with atrial fibrillation (AF). Recent advances in catheter and mapping technology …

Background Hypertrophic cardiomyopathy (HCM) patients may develop interatrial activation
delay, indicated by a complete separation of the right and left atrial activation on the ECG …

Aims In patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF),
radiofrequency catheter ablation (RFCA) represents a promising option. However, the …

A young boy aged 11 years died suddenly while watching his friends play basketball. He
was the third of 4 siblings and had been diagnosed with nonobstructive hypertrophic …